Literature DB >> 26585145

Use of Reporter Genes to Analyze Estrogen Response: The Transgenic Zebrafish Model.

Daniel A Gorelick1, Caroline Lucia Pinto2, Ruixin Hao3,4, Maria Bondesson5.   

Abstract

In vivo models to detect estrogenic compounds are very valuable for screening for endocrine disruptors. Here we describe the use of transgenic estrogen reporter zebrafish as an in vivo model for identification of estrogenic properties of compounds. Live imaging of these transgenic fish provides knowledge of estrogen receptor specificity of different ligands as well as dynamics of estrogen signaling. Coupled to image analysis, the model can provide quantitative dose-response information on estrogenic activity of chemical compounds.

Entities:  

Keywords:  Estrogen; Fluorescence microscopy; Image analysis; Transgenic zebrafish; Xenoestrogens

Mesh:

Substances:

Year:  2016        PMID: 26585145     DOI: 10.1007/978-1-4939-3127-9_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Zebrafish in Toxicology and Environmental Health.

Authors:  Kathryn Bambino; Jaime Chu
Journal:  Curr Top Dev Biol       Date:  2016-12-21       Impact factor: 4.897

2.  Differential activity of BPA, BPAF and BPC on zebrafish estrogen receptors in vitro and in vivo.

Authors:  Caroline Pinto; Ruixin Hao; Marina Grimaldi; Savini Thrikawala; Abdelhay Boulahtouf; Selim Aït-Aïssa; François Brion; Jan-Åke Gustafsson; Patrick Balaguer; Maria Bondesson
Journal:  Toxicol Appl Pharmacol       Date:  2019-08-12       Impact factor: 4.219

3.  Glucocorticoid deficiency causes transcriptional and post-transcriptional reprogramming of glutamine metabolism.

Authors:  Meltem Weger; Benjamin D Weger; Benjamin Görling; Gernot Poschet; Melek Yildiz; Rüdiger Hell; Burkhard Luy; Teoman Akcay; Tülay Güran; Thomas Dickmeis; Ferenc Müller; Nils Krone
Journal:  EBioMedicine       Date:  2018-09-26       Impact factor: 8.143

Review 4.  Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials.

Authors:  E Elizabeth Patton; Leonard I Zon; David M Langenau
Journal:  Nat Rev Drug Discov       Date:  2021-06-11       Impact factor: 112.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.